Publications
- A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes2013 | Publication without faculty affiliation
- Changes associated with lenalidomide treatment in the gene expression profiles of patients with Del(5q)2012 | First Faculty of Medicine
- Recurrent chromosomal breakpoints in patients with myelodysplastic syndromes and complex karyotype versus fragile sites2012 | First Faculty of Medicine
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | First Faculty of Medicine
- Therapy-related myelodysplastic syndrome : a retrospective analysis of data from the Czech Working MDS Group registry2009 | First Faculty of Medicine
- Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome2009 | First Faculty of Medicine
- Analysis of myelodysplastic syndrome patients with deletion of long arm of chromosome 5 followed up by the Czech MDS Working Group. Significance for the diagnostic and prognostic assessment2009 | First Faculty of Medicine
- Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome2009 | First Faculty of Medicine
- Manuál MDS. Sponzorované vydání pro PS MDS při České hematolaogické společnosti2006 | First Faculty of Medicine
- Lenalidomide treatment of patients with 5q- syndrome affects genes located in the TNF pathwayPublication without faculty affiliation
Loading network view...